High rates of diagnostic discordance and co‐pathology: Insights into PSP from the NACC dataset
Open Access
- 9 May 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (5) , e70248
Abstract
INTRODUCTION: Clinical features associated with accurate clinico‐pathologic correlation within cognitive‐predominant progressive supranuclear palsy (PSP) presentations have not been extensively studied. We identified features affecting PSP diagnosis within the National Alzheimer's Coordinating Center (NACC) dataset, a cognitive/behavioral research database.METHODS: Autopsied NACC participants with clinical or neuropathologic PSP diagnoses were categorized by diagnostic modality (Clinical‐only, Neuropathology‐only, both). Group differences in clinical, demographic, neuropsychologic, and neuropathologic features were assessed.RESULTS: Only 38.8% of neuropathologically identified PSP had clinical PSP diagnosis while 63.5% of clinically identified PSP had PSP pathology. Neuropathology‐only cases had fewer motor symptoms and better processing speed/executive functioning than the Clinical‐Neuropathology group. Nearly 70% demonstrated co‐neuropathologies including Alzheimer‐type, Lewy body, and corticobasal degeneration pathologies.DISCUSSION: Within NACC, discordant clinical and neuropathologic PSP diagnoses highlight the heterogeneity of PSP presentation, possibly driven by reliance on “classic” ante mortem symptoms. Further studies should assess the impact of co‐pathology on clinical neurodegenerative disease presentations.Highlights: A high rate of clinico‐pathologic PSP diagnostic discordance is seen within NACC. Cases without clinical PSP diagnosis had fewer classic motor and cognitive symptoms. Isolated PSP neuropathology is uncommon, with nearly 70% showing co‐neuropathology.Keywords
Funding Information
- Association for Frontotemporal Degeneration
- National Institute of Neurological Disorders and Stroke (R35‐NS122302)
- National Institute on Aging (P30AG07293, T32‐AG062403)
- American Brain Foundation
This publication has 56 references indexed in Scilit:
- Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonismBrain, 2005
- Accuracy of clinical diagnosis of progressive supranuclear palsyMovement Disorders, 2003
- Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain BankMovement Disorders, 2003
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002
- Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological studyBrain, 1997
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996
- Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related DisordersJournal of Neuropathology & Experimental Neurology, 1996
- Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Slowing of Cognitive Processing in Progressive Supranuclear PalsyArchives of Neurology, 1988
- Progressive Supranuclear PalsyArchives of Neurology, 1964